✦ LIBER ✦

Long-term effects of dalfampridine in patients with multiple sclerosis

✍ Scribed by Ruck, T.; Bittner, S.; Simon, O.J.; Göbel, K.; Wiendl, H.; Schilling, M.; Meuth, S.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic profile of dalfampridine

✍ Weir, Scott; Torkin, Risa; Henney III, Herbert R. 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 305 KB

Long-term Antibiotic Treatment with Roxi

✍ R. Woessner; M. T. Grauer; A. Frese; F. Bethke; T. Ginger; A. Hans; J. Treib 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 85 KB

Dalfampridine: Review on its recent deve

✍ Malhotra, Manav; Ghai, Pankaj; Narasimhan, Balasubramanian; Deep, Aakash 📂 Article 📅 2016 🏛 Elsevier 🌐 English ⚖ 422 KB

Population pharmacokinetics and pharmaco

✍ Weir, Scott; Gao, Yuying; Henney, Herbert R. 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 350 KB

Development of multiple sclerosis in pat

✍ Gold, Ralf; Kappos, Ludwig; Becker, Thomas 📂 Article 📅 1990 🏛 The Lancet 🌐 English ⚖ 359 KB

LONG-TERM TREATMENT OF MULTIPLE SCLEROSI

✍ Millar, J.H.D.; Vas, C.J.; Noronha, M.J.; Liversedge, L.A.; Rawson, M.D. 📂 Article 📅 1967 🏛 The Lancet 🌐 English ⚖ 465 KB